loading page

“Comment on: A review of the experience with pediatric written requests issued for oncology drug products.” Young patients with malignancies need reasonable studies with therapeutic intention.
  • +3
  • Klaus Rose,
  • Jane Grant-Kels,
  • Earl Ettienne,
  • Oishi Tanjinatus,
  • Pasquale Striano,
  • David Neubauer
Klaus Rose
klausrose Consulting
Author Profile
Jane Grant-Kels
UConn Health
Author Profile
Earl Ettienne
Howard University
Author Profile
Oishi Tanjinatus
Howard University
Author Profile
Pasquale Striano
University of Genoa
Author Profile
David Neubauer
University Children's Hospital Ljubljana
Author Profile

Peer review status:ACCEPTED

03 Feb 2021Submitted to Pediatric Blood & Cancer
03 Feb 2021Assigned to Editor
03 Feb 2021Submission Checks Completed
08 Feb 2021Editorial Decision: Accept